Christoph Krahenbuhl, IS Programme Manager for Pack Coding and Product Security at AstraZeneca, talks to Helen Winsor from Pharma IQ, about the challenges associated with pharmaceutical serialisation and traceability and how they are being addressed.

First, he explains how pharmaceutical packaging and anti-counterfeiting measures have evolved over the past five years, and outlines the current challenges associated with fighting counterfeiting and improving patient safety faced by the industry.

Next, the interview looks at the proposed solutions to help the industry overcome these challenges and reduce counterfeiting, and how these solutions can potentially be integrated into one optimal approach that is compliant with the various different coding requirements globally.

Krahenbuhl talks about the activities AstraZeneca has been involved in to formulate a strategic approach to the implementation of anti-counterfeiting measures. Finally, he offers his projections on what the future holds for anti-counterfeiting strategies and whether these strategies might put a halt to the increasing incidents of counterfeiting.

[inlinead]

  Have Your Say
Rate this feature and give us your feedback in the comments section below